How the U.S.’s intellectual property demands for the Trans-Pacific Partnership Agreement threaten access to medicines.

South African health activists and pharmaceutical industry stakeholders are keeping close watch over the government’s attempts to amend patent laws, which activists claim compromise the ability of the country’s poor majority to access cheaper generic medicines.

Call for further price cuts on cartridges and machines to realize goals of zero TB deaths.

PEPFAR, USAID, UNITAID and Bill & Melinda Gates Foundation have finalized an agreement to expand access to GeneXpert®, a molecular diagnostic system that provides a two-hour rapid diagnosis of TB, TB/HIV co-infection and drug-resistant TB.

It is possible to drastically reduce the morbidity and mortality associated with pediatric tuberculosis if case detection is improved and preventive therapy and curative treatment are made more accessible globally.

Progress towards reducing HIV-associated TB deaths can be achieved through attention to simple and deliverable actions on the ground.

Diabetes and TB represent a critical intersection between communicable and non-communicable diseases.

Termination of the use of streptomycin for re-treatment cases.

The study looks at 25 indicators in each country, ranging from coverage of ART and prevention of mother-to-child transmission, to whether nurses instead of doctors can start patients on HIV and TB treatment.

Lancet paper finds novel drug regimen could be more effective than existing treatments; TB Alliance’s trial to test drugs in combination saves years in research time.